https://www.alphaview.kr 실시간 미국 주식 뉴스를 AI로 분석하여 시장 정보를 제공합니다. ko Sun, 25 Oct 2026 10:13:59 GMT https://www.alphaview.kr/images/brand/logo.png https://www.alphaview.kr Copyright 2026 AlphaView. All rights reserved. contact@alphaview.kr (AlphaView) contact@alphaview.kr (AlphaView) 30 https://www.alphaview.kr/news/34104-릴레이-테라퓨틱스-보통주-공모-발표 Tue, 19 May 2026 20:03:00 GMT https://www.alphaview.kr/news/34104-릴레이-테라퓨틱스-보통주-공모-발표 금융/자금조달 globenewswire GlobeNewswire https://www.alphaview.kr/news/34358-릴레이-테라퓨틱스-pik3ca-관련-혈관-이상-환자에서-zovegalisib의-차별화된-안전성-및-효능-가능성을-입증하는-초기-임상-데이터-발표 Tue, 19 May 2026 10:00:00 GMT https://www.alphaview.kr/news/34358-릴레이-테라퓨틱스-pik3ca-관련-혈관-이상-환자에서-zovegalisib의-차별화된-안전성-및-효능-가능성을-입증하는-초기-임상-데이터-발표 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/37099-릴레이-테라퓨틱스-2026년-1분기-재무-결과-및-기업-업데이트-발표 Tue, 05 May 2026 20:05:00 GMT https://www.alphaview.kr/news/37099-릴레이-테라퓨틱스-2026년-1분기-재무-결과-및-기업-업데이트-발표 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/31778-relay-therapeutics-프론트라인-전이성-유방암에서-zovegalisib-atirmociclib-병용-요법의-추가-개발을-지지하는-임 Mon, 27 Apr 2026 10:02:22 GMT https://www.alphaview.kr/news/31778-relay-therapeutics-프론트라인-전이성-유방암에서-zovegalisib-atirmociclib-병용-요법의-추가-개발을-지지하는-임 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/19215-릴레이-테라퓨틱스-esmo-표적-항암-치료-학회-2026에서-zovegalisib-fulvestrant의-3상-용량-400mg-bid-경구-투여 Mon, 16 Mar 2026 11:01:03 GMT https://www.alphaview.kr/news/19215-릴레이-테라퓨틱스-esmo-표적-항암-치료-학회-2026에서-zovegalisib-fulvestrant의-3상-용량-400mg-bid-경구-투여 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/9556-relay-therapeutics-2025년-4분기-및-연간-재무-결과-및-기업-하이라이트-발표-예정-2026년-2월-26일 Thu, 19 Feb 2026 22:55:00 GMT https://www.alphaview.kr/news/9556-relay-therapeutics-2025년-4분기-및-연간-재무-결과-및-기업-하이라이트-발표-예정-2026년-2월-26일 바이오/헬스케어 globenewswire GlobeNewswire